Eva decides to sort out her bioburden issues after a disturbing dream...

Nominations for The Medicine Maker’s annual Innovation Awards will close on Tuesday November 6.

Sitting Down With…Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland

After many years of clinical trial failures in Alzheimer’s disease, pharma sees some positive results – although caution is recommended.

Does a medicine’s price consistently track with its benefits and value? Not in the US, according to a study.

A vaccine using mRNA demonstrates potential for broad influenza protection.

A new not-for-profit company will manufacture important generics in the US

A new comedy series focuses on pharma and a clinical trial gone wrong.

After many years of clinical trial failures in Alzheimer’s disease, pharma sees some positive results – although caution is recommended.

Women, like men, want good medicines that have been tested in clinical trials involving fair representation of both sexes.